Editorial Comment on "Efficacy of pembrolizumab plus lenvatinib as first-line treatment for metastatic renal cell carcinoma with multiple brain metastases".
Saved in:
| Title: | Editorial Comment on "Efficacy of pembrolizumab plus lenvatinib as first-line treatment for metastatic renal cell carcinoma with multiple brain metastases". |
|---|---|
| Authors: | Kato M; Department of Urology Aichi Cancer Center Hospital Nagoya Aichi Japan. |
| Source: | IJU case reports [IJU Case Rep] 2024 Nov 12; Vol. 8 (1), pp. 9-10. Date of Electronic Publication: 2024 Nov 12 (Print Publication: 2025). |
| Publication Type: | Editorial |
| Journal Info: | Publisher: John Wiley & Sons Australia, Ltd Country of Publication: Australia NLM ID: 101764958 Publication Model: eCollection Cited Medium: Internet ISSN: 2577-171X (Electronic) Linking ISSN: 2577171X NLM ISO Abbreviation: IJU Case Rep Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2577-171X |
|---|---|
| DOI: | 10.1002/iju5.12805 |
